Agile Therapeutics reported $12.76M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aceto ACET:US 5.21M 188K
Adma Biologics ADMA:US $ 13.87M 631.53K
Agile Therapeutics AGRX:US $ 12.76M 3.07M
Bayer BAYN:GR 3.77B 19M
Biodelivery Sciences International BDSI:US $ 25.47M 311K
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
JAZZ PHA JAZZ:US 363.68M 65.35M
Johnson & Johnson JNJ:US $ 6B 73M
Merk MRK:US $ 2.27B 9M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Pain Therapeutics PTIE:US $ 1.71M 475K
Pfizer PFE:US $ 2.73B 61M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Therapeuticsmd TXMD:US 58.44M 6.4M